Tower Research Capital (TRC)’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-19,675
| Closed | -$1.97K | – | 5108 |
|
|
2025
Q4 | $1.97K | Sell |
19,675
-14,680
| -43% | -$9.33K | ﹤0.01% | 4606 |
|
|
2025
Q3 | $20.8K | Sell |
34,355
-1,868
| -5% | -$880 | ﹤0.01% | 3277 |
|
|
2025
Q2 | $11.3K | Buy |
36,223
+16,768
| +86% | +$6.49K | ﹤0.01% | 3918 |
|
|
2025
Q1 | $9.51K | Sell |
19,455
-4,970
| -20% | -$2.93K | ﹤0.01% | 3765 |
|
|
2024
Q4 | $20.9K | Buy |
24,425
+23,893
| +4,491% | +$150K | ﹤0.01% | 3152 |
|
|
2024
Q3 | $4.52K | Buy |
+532
| New | +$3.13K | ﹤0.01% | 4515 |
|
|
2024
Q2 | – | Sell |
-10,261
| Closed | -$69.8K | – | 5669 |
|
|
2024
Q1 | $69.8K | Sell |
10,261
-12,914
| -56% | -$58K | ﹤0.01% | 2056 |
|
|
2023
Q4 | $77.6K | Sell |
23,175
-12,268
| -35% | -$30.5K | ﹤0.01% | 2832 |
|
|
2023
Q3 | $88.3K | Buy |
35,443
+27,963
| +374% | +$46.1K | ﹤0.01% | 2073 |
|
|
2023
Q2 | $9.57K | Buy |
7,480
+672
| +10% | +$891 | ﹤0.01% | 4253 |
|
|
2023
Q1 | $6K | Buy |
6,808
+1,730
| +34% | +$1.7K | ﹤0.01% | 4819 |
|
|
2022
Q4 | $4K | Sell |
5,078
-5,368
| -51% | -$4.25K | ﹤0.01% | 4970 |
|
|
2022
Q3 | $10K | Sell |
10,446
-215
| -2% | -$258 | ﹤0.01% | 4508 |
|
|
2022
Q2 | $10K | Buy |
10,661
+4,799
| +82% | +$7.86K | ﹤0.01% | 4424 |
|
|
2022
Q1 | $13K | Buy |
5,862
+1,593
| +37% | +$4.27K | ﹤0.01% | 3953 |
|
|
2021
Q4 | $38K | Buy |
4,269
+3,157
| +284% | +$41.5K | ﹤0.01% | 2993 |
|
|
2021
Q3 | $18K | Sell |
1,112
-345
| -24% | -$5.96K | ﹤0.01% | 3799 |
|
|
2021
Q2 | $31K | Sell |
1,457
-302
| -17% | -$5.72K | ﹤0.01% | 3442 |
|
|
2021
Q1 | $33K | Buy |
1,759
+23
| +1% | +$496 | ﹤0.01% | 3477 |
|
|
2020
Q4 | $38K | Sell |
1,736
-11,414
| -87% | -$238K | ﹤0.01% | 3363 |
|
|
2020
Q3 | $273K | Buy |
13,150
+10,442
| +386% | +$271K | ﹤0.01% | 2263 |
|
|
2020
Q2 | $98K | Buy |
+2,708
| New | +$113K | ﹤0.01% | 2471 |
|
|
2020
Q1 | – | Sell |
-792
| Closed | -$22K | – | 3006 |
|
|
2019
Q4 | $22K | Buy |
+792
| New | +$13.6K | ﹤0.01% | 1848 |
|
|
2019
Q3 | – | Sell |
-494
| Closed | -$4K | – | 4057 |
|
|
2019
Q2 | $4K | Buy |
+494
| New | +$4.68K | ﹤0.01% | 3003 |
|
Tower Research Capital (TRC)'s APLT Position: Q1 2026 in Review
Tower Research Capital (TRC) sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 19,675 shares — an estimated $1.97K sold.
Tower Research Capital (TRC) first reported a position in APLT in Q2 2019 and held it in 24 quarters. The position peaked at $273K in Q3 2020. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Tower Research Capital (TRC) reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 19,675 Applied Therapeutics shares in Q1 2026, an estimated $1.97K.
- Tower Research Capital (TRC) first reported a position in Applied Therapeutics in Q2 2019 and held it in 24 quarters.
- Tower Research Capital (TRC)'s Applied Therapeutics position peaked at $273K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.